• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

Spinal Simplicity Announces FDA Clearance of Freedom Decompression System™

April 23, 2026 By SPINEMarketGroup

Spinal Simplicity announced FDA clearance of Freedom DS, a minimally invasive system for lumbar spinal stenosis designed to improve procedural control and efficiency.

OVERLAND PARK, Kan., April 23, 2026 /PRNewswire-PRWeb/ — Spinal Simplicity today announced FDA clearance of the Freedom Decompression System™ (Freedom DS), a minimally invasive solution designed to treat lumbar spinal stenosis through targeted decompression.

The system introduces enhanced instrumentation designed to improve procedural control and efficiency, including integrated depth gauges in each of the bone and tissue tools, optimized angle management, and instrumentation designed to remove more tissue with fewer passes.

“Freedom DS was designed with precision and purpose, expanding our ability to treat the right patient with the right solution.” — Todd Moseley, CEO of Spinal Simplicity

Freedom DS expands Spinal Simplicity’s portfolio, enabling physicians to treat patients with both percutaneous decompression and indirect decompression with stabilization—supporting a more complete, patient-specific approach to care.

“Freedom DS was designed with precision and purpose,” said Todd Moseley, CEO of Spinal Simplicity.”Every instrument is thoughtfully engineered to enhance control, helping physicians work more efficiently. Most importantly, this expands our ability to treat the right patient with the right solution, all rooted in our mission to put patients first and help them get their freedom back.”

“Advancements in instrumentation matter,” said Timothy Deer, MD, Chairman of American Society of Pain and Neuroscience. “The enhanced design of Freedom DS allows for greater procedural efficiency—enabling physicians to accomplish more with less motion. That level of control is critical in minimally invasive spine procedures. More importantly, innovations like this push the entire field forward—and ultimately benefit patients.”

The company will initiate a phased limited market release, beginning with a controlled trial phase, with a full commercial launch expected later in 2026.

About Spinal Simplicity

Spinal Simplicity is a medical device company focused on developing minimally invasive solutions that address the root causes of back and or leg pain. The company partners closely with physicians to design technologies grounded in biomechanics and real-world patient needs, expanding access to effective treatments in the outpatient setting. Through a commitment to innovation, education, and patient-first care, Spinal Simplicity is helping patients get their freedom back.

Media Contact

Parker Snedden, VP of Marketing, Spinal Simplicity, 1 (913) 451-4414, psnedden@spinalsimplicity.com, https://spinalsimplicity.com

Jonathan Hess, VP of Investor Relations, Spinal Simplicity, 1 (913) 451-4414, Jonathan.hess@spinalsimplicity.com, https://spinalsimplicity.com

SOURCE Spinal Simplicity

Related Posts:

  • Spinal Simplicity Announces FDA Clearance of…
  • Spinal Simplicity Announces Regulatory Clearance for…
  • Allevion Medical™ Receives 510K Clearance for…

Filed Under: NEWS Tagged With: 2026

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE

POPULAR POST LAST 90 DAYS

  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • BROCHURES
  • Globus Medical: Stronger in Spine, but Could DePuy…
  • PRODUCT LIBRARY
  • Who Is Really Winning the Mid-Tier Spine…
  • Globus Medical’s Strategy: Building a Closed-Loop…
  • Johnson & Johnson Explores Potential $20B Sale…
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • What Is Medtronic’s PILAR™ Technique?
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Globus Medical Reports Fourth Quarter and Full Year…
  • From Niche to Momentum: The Rapid Rise of Spinal…
  • Single-Use Spine Surgery Systems: The Future or…
  • Behind the Deal: The Strategic Logic of Zavation’s…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • Expandable cages were adopted not because they fused…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • VB Spine Announces Successful First Clinical Cases…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • From Early Innovations to Modern Practice: Where Are…
  • VB Spine Announces VB Spine Solutions, a…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • ATEC’s Valence: Robotics in Service of a Procedural Strategy
  • Globus Medical Reports First Quarter 2026 Results
  • LAST 5 VIDEOS PUBLISHED

    1. REACH Medical: Expandable PLIF/TLIF Cage
    2. Expanding Innovations: X-PAC®TLIF 
    3. SI-BONE: iFuse INTRA Ti™ Implant System
    4. Globus Medical: IntraLIF™ Cannulated
    5. SI-BONE: iFuse TORQ TNT® Implant System

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup